Trial of Telbivudine Combination Therapy vs. Continued Adefovir Monotherapy
Status:
Withdrawn
Trial end date:
1969-12-31
Target enrollment:
Participant gender:
Summary
The purpose of this study is to find out if taking a combination of telbivudine and adefovir
or tenofovir and telbivudine can lower the amount of Hepatitis B virus in patients that have
been taking adefovir alone for at least 5 months and have had less than optimal responses.
The safety of taking telbivudine and adefovir together or tenofovir and telbivudine together
will also be studied.